Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways
- PMID: 25719313
- DOI: 10.1515/hsz-2014-0302
Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways
Abstract
The prevailing mechanisms of action of traditional chemotherapeutic agents have been challenged by sphingolipid cancer research. Many studies have shown that ceramide generation in response to cytotoxic agents is central to tumor cell death. Ceramide can be generated either via hydrolysis of cell-membrane sphingomyelin by sphingomyelinases, hydrolysis of cerebrosides, or via de novo synthesis by ceramide synthases. Ceramide can act as a second messenger for apoptosis, senescence or autophagy. Inherent or acquired alterations in the sphingolipid pathway can account for resistance to the classic chemotherapeutic agents. In particular, it has been shown that activation of the acid ceramidase can lead to the formation of sphingosine 1-phosphate, which then antagonizes ceramide signaling by initiating a pro-survival signaling pathway. Furthermore, ceramide glycosylation catalyzed by glucosylceramide synthase converts ceramide to glucosylceramide, thus eliminating ceramide and consequently protecting cancer cells from apoptosis. In this review, we describe the effects of some of the most commonly used chemotherapeutic agents on ceramide generation, with a particular emphasis on strategies used to enhance the efficacy of these agents.
Similar articles
-
Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Future Oncol. 2010 Oct;6(10):1603-24. doi: 10.2217/fon.10.116. Future Oncol. 2010. PMID: 21062159 Free PMC article. Review.
-
Targeting the ceramide system in cancer.Cancer Lett. 2013 May 28;332(2):286-94. doi: 10.1016/j.canlet.2011.07.010. Epub 2011 Jul 23. Cancer Lett. 2013. PMID: 21862212 Review.
-
Ceramide synthesis and metabolism as a target for cancer therapy.Cancer Lett. 2004 Apr 8;206(2):169-80. doi: 10.1016/j.canlet.2003.08.034. Cancer Lett. 2004. PMID: 15013522 Review.
-
Cancer treatment strategies targeting sphingolipid metabolism.Adv Exp Med Biol. 2010;688:185-205. doi: 10.1007/978-1-4419-6741-1_13. Adv Exp Med Biol. 2010. PMID: 20919655 Free PMC article. Review.
-
Sphingolipids and response to chemotherapy.Handb Exp Pharmacol. 2013;(216):73-91. doi: 10.1007/978-3-7091-1511-4_4. Handb Exp Pharmacol. 2013. PMID: 23563652 Review.
Cited by
-
Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.Br J Cancer. 2018 Oct;119(7):847-854. doi: 10.1038/s41416-018-0270-z. Epub 2018 Oct 8. Br J Cancer. 2018. PMID: 30293997 Free PMC article.
-
The Lipidomic Analyses in Low and Highly Aggressive Ovarian Cancer Cell Lines.Lipids. 2016 Feb;51(2):179-87. doi: 10.1007/s11745-015-4108-7. Epub 2015 Dec 10. Lipids. 2016. PMID: 26661829
-
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease.J Clin Med. 2021 Feb 16;10(4):792. doi: 10.3390/jcm10040792. J Clin Med. 2021. PMID: 33669443 Free PMC article. Review.
-
The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer Treatment.Int J Mol Sci. 2024 Sep 11;25(18):9825. doi: 10.3390/ijms25189825. Int J Mol Sci. 2024. PMID: 39337312 Free PMC article. Review.
-
Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy.Sci Rep. 2024 Jul 31;14(1):17708. doi: 10.1038/s41598-024-68820-x. Sci Rep. 2024. PMID: 39085429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
